N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Dr. Katherine Tkaczuk is the Director of the Breast Evaluation and Treatment Program at the University of Maryland School of Medicine, Marlene and Stewart Greenebaum Cancer Center. She earned both her undergraduate and Medical Doctor degrees from Wroclaw Medical Academy in Wroclaw, Poland, and conducted research at the Pathology Department of Hahnemann Hospital. Her research interests include clinical drug development in breast cancer (stages 1–4), clinical trials in early and advanced breast cancer (Phases 1–), circulating tumor cells, GP-88, and the drug response indicator test.

N/A

Dr. Jocelyn Reader is an Assistant Professor in the Department of Pharmaceutical Sciences at the University of Maryland Eastern Shore and the University of Maryland School of Medicine. She earned her B.A. in Biological Sciences from Goucher College and completed her Ph.D. in Human Genetics at the University of Maryland School of Medicine in 2009. Her current research focuses on the role of inflammation in the response of ovarian cancer to chemotherapeutic agents and the role of PGE2 EP receptors in breast cancer disparities. Her research interests include cancer health disparities, breast and gynecologic cancers, and molecular and cellular oncobiology.

Dr. Tonya Webb earned a B.S. in Biology from Prairie View A&M University and a Ph.D. in Microbiology and Immunology from Indiana University. She is currently an Associate Professor in the Department of Microbiology and Immunology at the University of Maryland School of Medicine. Research areas championed by her group include the development of novel cancer immunotherapeutic strategies and research into cancer health disparities.